Michelle Graham
CIK 1506315 · Chief Human Resources Officer · last filed 2023-03-02
Michelle Graham is a Chief Human Resources Officer who has filed 27 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing, for ALBO, was dated Mar 2, 2023. Across all open-market trades the lifetime net is −$116.9K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
27
-$116.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALBIREO PHARMA, INC. (ALBO) Delisted | Chief Human Resources Officer | 0 | $44.15 | $0 | -$100.7K | 13 | 2023-03-02 |
| PAREXEL INTERNATIONAL CORP (PRXL) Delisted | SVP, Chief HR Officer | 9,941 | — | — | $0 | 3 | 2017-09-18 |
| Integer Holdings Corp (GB) Delisted | Sr. VP Human Resources | 24,723 | $7.49 | $185.2K | -$16.1K | 10 | 2014-08-11 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-02 | ALBIREO PHARMA, INC. (ALBO) Delisted | Mixed | −5,543 | $0 | EDGAR |
| 2023-01-27 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +32,000 | $0 | EDGAR |
| 2023-01-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +32,000 | $0 | EDGAR |
| 2023-01-23 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −102 | -$4.5K | EDGAR |
| 2023-01-20 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −1,774 | -$77.9K | EDGAR |
| 2022-10-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −104 | -$2.0K | EDGAR |
| 2022-07-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −106 | -$2.6K | EDGAR |
| 2022-04-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −103 | -$3.4K | EDGAR |
| 2022-01-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −418 | -$10.3K | EDGAR |
| 2022-01-20 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +21,600 | $0 | EDGAR |